4//SEC Filing
Williams Laura A 4
Accession 0001869194-26-000002
CIK 0001437402other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:59 PM ET
Size
9.1 KB
Accession
0001869194-26-000002
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Williams Laura A
Chief Patient Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-08$0.99/sh+50,000$49,500→ 409,896 total - Sale
Common Stock
2026-01-08$6.98/sh−50,000$348,900→ 361,563 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-08−0→ 62,000 totalExercise: $0.99Exp: 2032-01-06→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades in prices ranging from $6.97 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F2]Reflects the adjusted total which includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan in August 2025.
- [F3]The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
ARDELYX, INC.
CIK 0001437402
Entity typeother
Related Parties
1- filerCIK 0001869194
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:59 PM ET
- Size
- 9.1 KB